SION
Sionna Therapeutics, Inc.
$36.54
%
Analyst Rating:Buy

Stock Details

CEO

Michael Cloonan

Sector

Healthcare

Industry

Biotechnology

Full Time Employees

41

Address

21 Hickory Drive Suite 500, Waltham, MA, 02451

Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.

Income Statement  

Financials

Selected Year

Revenue Estimates

EPS Estimates

Net Income Estimates

Price target for Sionna Therapeutics, Inc.  $36.54

EPS

Revenue

Congress Tracker 

Insider Trading of Key Employees

Financial News: SION